A5008414963- Pharmaceutical Economics and Policy
- Innovation and Socioeconomic Development
- Health Systems, Economic Evaluations, Quality of Life
- Biotechnology and Related Fields
- Vaccine Coverage and Hesitancy
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Pandemic Impacts
- Vibrio bacteria research studies
- Intellectual Property and Patents
- Hepatitis C virus research
- Mobile Health and mHealth Applications
- ICT in Developing Communities
- COVID-19 Digital Contact Tracing
Graduate Institute of International and Development Studies
2023-2025
Abstract Background Unequal and inequitable access to Covid-19 vaccines in low- middle-income countries (L&MICs) was a major political, ethical public health failure the pandemic. However, vaccine developers’ practices were not monolithic, but rather, took diverse approaches supplying different countries, with important implications for global access. Results Using data on R&D investments, regulatory approvals, manufacturing purchase agreements, deliveries, we identified six distinct...
Background The current mainstream pharmaceutical innovation system (PIS) is driven by the market-based logic of charging highest prices societies will bear. Outcomes include unaffordable medicines, restricted access and pressure on health budgets. How can change to deliver fairly-priced medicines?
Cholera outbreaks have been rapidly increasing around the world. While long-term cholera prevention and control measures rely on improvements in water, sanitation, hygiene, oral vaccines (OCVs) are used for short-to-medium term. OCVs lack market incentives available other more profitable disease areas. The development of was made possible through an alternative innovation model, which sustained across multiple generations product than three decades. To examine how this model worked, we...
Introduction Digital health offers the potential to strengthen systems in low- and middle-income countries. However, experts have warned about threats human rights. Methods We used qualitative methods investigate how young adults Ghana, Kenya Vietnam use their mobile phones access online information peer support, what they see as effect on applied a transnational participatory action research approach. Global national networks of people living with HIV, AIDS activists, rights lawyers...
There is growing interest in pharmaceutical innovation low- and middle-income countries (LMICs), but information on existing activities, capacities, outcomes scarce. We mapped available data at the global level, studied national systems of Bangladesh Colombia to shed light research development (R&D) Global South, including challenges prospects, help fill knowledge gaps. gathered analyzed from three types sources: literature, semi-structured interviews with key informants, publicly R&D...
Alternative innovation models have emerged to address failures of the traditional pharmaceutical system, particularly for diseases where market incentives do not attract sufficient research and development efforts. However, feasibility such with significant markets is well-established. This article analyses a novel drug (ravidasvir) treatment hepatitis C, highly profitable market. Data from qualitative methods, including literature reviews semi-structured interviews, was analyzed using...
Abstract 3.1. Background Unequal and inequitable access to Covid-19 vaccines in low- middle-income countries (L&MICs) was a major political, ethical public health failure the pandemic. However, vaccine developers’ practices were not monolithic, but rather, took diverse approaches supplying different countries, with important implications for global access. 3.2. Results Using data on R&D investments, regulatory approvals, manufacturing purchase agreements, deliveries, we identified...